Effectiveness of Nonpharmacologic Interventions in Systemic Sclerosis: A Systematic Review

Arthritis Care and Research

Volumn 67, Issue 10, 2015, Pages 1426-1439

  Willems, Linda M ^a   Vriezekolk, Johanna E ^a   Schouffoer, Anne A ^b   Poole, Janet L ^c   Stamm, Tanja A ^d   Boström, Carina ^e   Kwakkenbos, Linda ^f   Vliet Vlieland, Theodora P M ^b   Van Den Ende, Cornelia H M ^a  

^a SINT MAARTENSKLINIEK   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e KAROLINSKA INSTITUTE   (Sweden)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBIC EXERCISE; ARTICLE; BALNEOTHERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); EXERCISE; FEEDBACK SYSTEM; GRIP STRENGTH; HAND FUNCTION; HUMAN; JAW MOVEMENT; KINESIOTHERAPY; LYMPHATIC DRAINAGE; MASSAGE; METHODOLOGY; MOUTH HYGIENE; OBSERVATIONAL STUDY; OROFACIAL EXERCISE; PATIENT EDUCATION; PHYSICAL CAPACITY; PHYSICAL DISABILITY; PHYSIOTHERAPY; PSYCHOEDUCATION; PSYCHOLOGICAL WELL BEING; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SELF CARE; STRETCHING EXERCISE; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; TAI CHI; TOTAL PARENTERAL NUTRITION; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; ULTRASOUND THERAPY; FEMALE; FOLLOW UP; MALE; PROCEDURES; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC;

CONTROLLED CLINICAL TRIALS AS TOPIC; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OBSERVATIONAL STUDIES AS TOPIC; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 84942133788     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22595     Document Type: Article

References (57)

1. Katsumoto TR, Whitfield ML, Connolly MK,. The pathogenesis of systemic sclerosis. Annu Rev Pathol 2011; 6: 509-37.
2. Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD,. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian national survey. Rheumatology (Oxford) 2011; 50: 762-7.
3. Willems LM, Kwakkenbos L, Bode C, van den Hoogen FH, van den Ende CH,. Health care use and patients' perceptions of quality of care in systemic sclerosis. Clin Exp Rheumatol 2013; 31 Suppl 76: S64-70.
4. Sandusky SB, McGuire L, Smith MT, Wigley FM, Haythornthwaite JA,. Fatigue: an overlooked determinant of physical function in scleroderma. Rheumatology (Oxford) 2009; 48: 165-9.
5. Schieir O, Thombs BD, Hudson M, Boivin J, Steele R, Bernatsky S, et al., and the Canadian Scleroderma Research Group. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2010; 62: 409-17.
6. Benrud-Larson LM, Haythornthwaite JA, Heinberg LJ, Boling C, Reed J, White B, et al., The impact of pain and symptoms of depression in scleroderma. Pain 2002; 95: 267-75.
7. Schnitzer M, Hudson M, Baron M, Steele R, and the Canadian Scleroderma Research Group. Disability in systemic sclerosis: a longitudinal observational study. J Rheumatol 2011; 38: 685-92.
8. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, et al., Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 2009; 61: 1112-20.
9. Thombs BD, Taillefer SS, Hudson M, Baron M,. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007; 57: 1089-97.
10. American College of Rheumatology and Association of Rheumatology Health Professionals. Multidisciplinary care for patients with rheumatic and musculoskeletal diseases: the Rheumatology Health Care Team. Position statement. URL: http://www.rheumatology.org/assets/0/116/525/526/555/d0532772-f61d-4fd0-a16f-971fd5b67905.pdf.
11. Bremander A, Bergman S,. Non-pharmacological management of musculoskeletal disease in primary care. Best Pract Res Clin Rheumatol 2008; 22: 563-77.
12. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al., EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009; 68: 620-8.
13. Poole JL,. Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol 2010; 22: 205-12.
14. Casale R, Buonocore M, Matucci-Cerinic M,. Systemic sclerosis (scleroderma): an integrated challenge in rehabilitation. Arch Phys Med Rehabil 1997; 78: 767-73.
15. Alantar A, Cabane J, Hachulla E, Princ G, Ginisty D, Hassin M, et al., Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2011; 63: 1126-33.
16. Van Tulder M, Furlan A, Bombardier C, Bouter L, and the Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane collaboration back review group. Spine 2003; 28: 1290-9.
17. Downs SH, Black N,. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-84.
18. Ghogomu EA, Maxwell LJ, Buchbinder R, Rader T, Pardo J, Johnston RV, et al., Updated method guidelines for Cochrane musculoskeletal group systematic reviews and metaanalyses. J Rheumatol 2014; 41: 194-205.
19. Maxwell L, Santesso N, Tugwell PS, Wells GA, Judd M, Buchbinder R,. Method guidelines for Cochrane musculoskeletal group systematic reviews. J Rheumatol 2006; 33: 2304-11.
20. Deeks JJ, Dinnes J, D'Amico R, Sowden AJ, Sakarovitch C, Song F, et al., Evaluating non-randomised intervention studies. Health Technol Assess 2003; 7: 1-173.
21. Samoocha D, Bruinvels DJ, Elbers NA, Anema JR, van der Beek AJ,. Effectiveness of web-based interventions on patient empowerment: a systematic review and meta-analysis. J Med Internet Res 2010; 12: e23.
22. Livingston JD, Milne T, Fang ML, Amari E,. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction 2012; 107: 39-50.
23. Cohen J,. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.
24. Yuen HK, Weng Y, Bandyopadhyay D, Reed SG, Leite RS, Silver RM,. Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol 2011; 29 Suppl 65: S26-32.
25. Yuen HK, Marlow NM, Reed SG, Mahoney S, Summerlin LM, Leite R, et al., Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil 2012; 34: 84-9.
26. Pai YC,. The need for nursing instruction in patients receiving steroid pulse therapy for the treatment of autoimmune diseases and the effect of instruction on patient knowledge. BMC Musculoskeletal Disord 2010; 11: 217.
27. Poole J, Conte C, Brewer C, Good CC, Perella D, Rossie KM, et al., Oral hygiene in scleroderma: the effectiveness of a multi-disciplinary intervention program. Disabil Rehabil 2010; 32: 379-84.
28. Pizzo G, Scardina GA, Messina P,. Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig 2003; 7: 175-8.
29. Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, van der Giesen FJ, de Jong Z, Stolk J, et al., Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2011; 63: 909-17.
30. Kwakkenbos L, Bluyssen SJ, Vonk MC, van Helmond AF, van den Ende CH, van den Hoogen FH, et al., Addressing patient health care demands in systemic sclerosis: pre-post assessment of a psycho-educational group programme. Clin Exp Rheumatol 2011; 29 Suppl 65: S60-5.
31. Poole JL, Skipper B, Mendelson C,. Evaluation of a mail-delivered, print-format, self-management program for persons with systemic sclerosis. Clin Rheumatol 2013; 32: 1393-8.
32. Poole JL, Mendelson C, Skipper B, Khanna D,. Taking charge of systemic sclerosis: a pilot study to assess the effectiveness of an internet self-management program. Arthritis Care Res (Hoboken) 2014; 66: 778-82.
33. Antonioli CM, Bua G, Frige A, Prandini K, Radici S, Scarsi M, et al., An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheumatol 2009; 28: 159-65.
34. Maddali Bongi S, Del Rosso A, Galluccio F, Tai G, Sigismondi F, Passalacqua M, et al., Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol 2009; 27 Suppl 54:S 44-50.
35. Maddali Bongi S, Del Rosso A, Gallucio F, Sigismondi F, Miniati I, Conforti ML, et al., Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol 2009; 28: 1167-73.
36. Maddali-Bongi S, Landi G, Galluccio F, Del Rosso A, Miniati I, Conforti ML, et al., The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat's technique and kinesitherapy: a randomized controlled trial. Rheumatol Int 2011; 31: 895-901.
37. Pinto AL, Oliveira NC, Gualano B, Christmann RB, Painelli VS, Artioli GG, et al., Efficacy and safety of concurrent training in systemic sclerosis. J Strength Cond Res 2011; 25: 1423-8.
38. Mugii N, Hasegawa M, Matsushita T, Kondo M, Orito H, Yanaba K, et al., The efficacy of self-administered stretching for finger joint motion in Japanese patients with systemic sclerosis. J Rheumatol 2006; 33: 1586-92.
39. Sandqvist G, Akesson A, Eklund M,. Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil 2004; 26: 981-7.
40. Pils K, Graninger W, Sadil F,. Paraffin hand bath for scleroderma. Phys Med Rehabil 1991; 1: 19-21.
41. Werner GT, Eder U,. Kohlensäurebäder in der Behandlung der progressiven systemischen Sklerodermie. Akt Rheumatol 1996; 21: 213-6.
42. Maddali Bongi S, Del Rosso A, Passalacqua M, Miccio S, Cerinic MM,. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res (Hoboken) 2011; 63: 1134-41.
43. Uhlemann C, Abendroth K, Callies R, Gassel M,. Mehrmals tägliche Utraschallanwendung bei Patienten mit progressive systemischer Sklerodermie. Dermatol Monatsschr 1990; 176: 323-6.
44. Tinazzi E, Amelio E, Marangoni E, Guerra C, Puccetti A, Codella OM, et al., Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int 2011; 31: 651-6.
45. Sporbeck B, Mathiske-Schmidt K, Jahr S, Huscher D, Becker M, Riemekasten G, et al., Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial. Rheumatol Int 2012; 32: 1469-73.
46. Sallam H, McNearney TA, Doshi D, Chen JD,. Transcutaneous electrical nerve stimulation (TENS) improves upper GI symptoms and balances the sympathovagal activity in scleroderma patients. Dig Dis Sci 2007; 52: 1329-37.
47. Jawa H, Fernandes G, Saqui O, Allard JP,. Home parenteral nutrition in patients with systemic sclerosis: a retrospective review of 12 cases. J Rheumatol 2012; 39: 1004-7.
48. Landis JR, Koch GG,. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
49. Coyne JC, Thombs BD, Hagedoorn M,. Ain't necessarily so: review and critique of recent meta-analyses of behavioural medicine interventions in health psychology. Health Psychol 2010; 29: 107-16.
50. Kraemer HC, Gardner C, Brooks JO, Yesavage JA,. Advantages of excluding underpowered studies in meta-analysis: inclusionist versus exclusionist viewpoints. Psychol Methods 1998; 3: 23-31.
51. Stamm TA, Mattsson M, Mihai C, Stocker J, Binder A, Bauernfeind B, et al., Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries. Ann Rheum Dis 2011; 70: 1074-9.
52. Van den Ende CH, Steultjens EM, Bouter LM, Dekker J,. Clinical heterogeneity was a common problem in Cochrane reviews of physiotherapy and occupational therapy. J Clin Epidemiol 2006; 59: 914-9.
53. Thombs BD, Kwakkenbos L, Coronado-Montoya S,. Trial registration in rheumatology: the next step. Arthritis Care Res (Hoboken) 2014; 66: 1435-7.
54. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al., CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012; 10: 28-55.
55. Beurskens AJ, de Vet HC, Koke AJ, Lindeman E, van der Heijden GJ, Regtop W, et al., A patient-specific approach for measuring functional status in low back pain. J Manipulative Physiol Ther 1999; 22: 144-8.
56. Pham T, van der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, et al., Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol 2003; 30: 1648-54.
57. Hoogeboom TJ, Stukstette MJ, de Bie RA, Cornelissen J, den Broeder AA, van den Ende CH,. Non-pharmacological care for patients with generalized osteoarthritis: design of a randomized clinical trial. BMC Musculoskelet Disord 2010; 11: 142.